Beckman Coulter, Inc. (BEC)
$64.58
-0.82 (-1.25%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $64.58 |
| Daily Range | $64.37 - $65.35 |
| 52-Week Range | $35.94 - $71.57 |
| Market Cap | $4.48B |
| P/E Ratio | 24.93 |
| Dividend (Yield) | 0.72 (1.10%) |
| Volume | 441,867 |
| Average Daily Volume | 604,000 |
BEC
VS S&P 500 (SPY)
How do you think BEC will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BEC Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BEC News and Commentary
- UPDATE 1-Beckman Coulter posts lower net on acquisition charges – Reuters
- 4 Stocks Losing Top Investor Support – The Motley Fool
- 3 Stocks Ready to Roar – The Motley Fool
- Rescue Your 401(k)! – The Motley Fool
- Don't Miss These Stocks – The Motley Fool
- Life – Blog at The Motley Fool
- Can't Beat BD's Steady Growth – The Motley Fool
- More Extrinsic Growth From Inverness on the Way – The Motley Fool
- Turnaround Time for Biotech? – The Motley Fool
- This Just In: Mergers Do Indeed Lower Costs – The Motley Fool
- Immucor Draws First Blood – The Motley Fool
- More Drugmaker Growth Without the FDA – The Motley Fool
- Extrinsic Growth From Inverness – The Motley Fool
- 2 Suitors Are Better Than 1 – The Motley Fool
- Another Boost for Immucor – The Motley Fool
- Beckman-Coulter Gets Diagnostic – The Motley Fool
Related News and Articles
- Don't Ignore These Incredible Returns – The Motley Fool
- 5-Star Stocks Poised to Pop: Stryker – The Motley Fool
RSS Headlines
Fool UK
